Bank of Montreal’s Lucid Diagnostics LUCD Stock Holding History

Bank of Montreal’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310K	Buy	289,936 +4,700	+2%	+$5.07K	﹤0.01%	2748
2026 Q1	$328K	Buy	285,236 +270,990	+1,902%	+$345K	﹤0.01%	2617
2025 Q4	$87.2K	Hold	14,246	–	–	﹤0.01%	3087
2025 Q3	$14.4K	Buy	+14,246	New	+$15.6K	﹤0.01%	3324
2022 Q3	–	Sell	-15,524	Closed	-$35K	–	4270
2022 Q2	$35K	Buy	+15,524	New	+$34.5K	﹤0.01%	3681

Other funds holding LUCD

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of Montreal's LUCD Position: Q2 2026 in Review

Bank of Montreal increased its Lucid Diagnostics (LUCD) stake by 1.6% in Q2 2026, buying an estimated $5.07K and bringing the position to 289,936 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Bank of Montreal first reported a position in LUCD in Q2 2022 and has held it in 5 quarters since. The position peaked at $328K in Q1 2026. 115 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

Bank of Montreal held 289,936 shares of Lucid Diagnostics worth $310K as of Q2 2026.
Bank of Montreal bought 4,700 Lucid Diagnostics shares in Q2 2026, an estimated $5.07K.
Lucid Diagnostics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2748 holding.
Bank of Montreal first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 5 quarters since.
Bank of Montreal's Lucid Diagnostics position peaked at $328K in Q1 2026.
115 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.